|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.80 USD | -0.48% |
|
+0.32% | +98.10% |
| 05-14 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 109M | - | - | - | ||
| 67.88B | |||||
| 53.23B | |||||
| 48.71B | |||||
| 38.98B | - | ||||
| 29.55B |
Select your edition
All financial news and data tailored to specific country editions
